GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Johnson & Johnson JNJ · USD

Health Care · Pharmaceuticals · US listing · 🇺🇸 United States

S&P 500Dow Jones

Compare

276.22

+1.43%

Close of 6 Nov 2026, in USD

Latest on Johnson & Johnson

Our reporting

Next results

20 Jan 2027

Due on 20 Jan 2027. Analysts expect earnings of 2.91 a share on revenue of $26.41bn.

Past results

Reported against what analysts expected

13 Oct 202615 Jul 202614 Apr 202621 Jan 202614 Oct 202516 Jul 2025
Earnings per share2.592.902.702.462.802.77
Forecast2.522.842.682.462.762.68
Revenue$25.40bn$25.31bn$24.06bn$24.56bn$23.99bn$23.74bn
Forecast$25.38bn$25.06bn$23.61bn$24.15bn$23.76bn$22.85bn

Key events

  1. 23 Aug 20231-to-1 reverse split
  2. 21 Aug 20231-to-1 reverse split
  3. 13 Jun 20012-for-1 share split
  4. 12 Jun 19962-for-1 share split
  5. 10 Jun 19922-for-1 share split
  6. 11 May 19892-for-1 share split

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.